ArticleTranslational pediatrics2025
Neonatal osteomyelitis: a case series and literature review.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neonatal Osteomyelitis Caused byChildren (Basel, Switzerland) · 2026Review
- Clinical characteristics, pathogenesis, treatment, and prognosis of bone and joint infections in neonates: a single-center report of 20 cases.BMC pediatrics · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonates have a number of risk factors that make them susceptible to bone and joint infections. Pathogens can access the bone through the bloodstream (hematogenous spread), direct inoculation (traumatic or procedural), or by contiguous spreading from nearby infected soft tissues or synovial fluid. Studies focused on neonatal osteomyelitis are very rare and most of them only involved a small number of cases. This study aimed to describe the cases of neonatal osteomyelitis in one of the largest neonatal intensive care units in China across a 6-year time period and to compare the results with those reported in the latest literature. Methods: This study retrospectively reviewed the data of clinical characteristics, etiologies and outcomes in neonates with osteomyelitis from 2016 to 2021 in Children's Hospital of Fudan University and compared our results with six large case series (>10 cases) of neonatal osteomyelitis reported in the past 30 years. Results: Fifteen neonates were identified, accounting for 0.05% of the total neonatal admissions. The median [interquartile range (IQR)] gestational age was 37.9 (IQR, 36.6-39.9) weeks, and one-third were preterm infants. The median (IQR) birth weight (BW) was 3,000 (IQR, 2,400-4,000) grams and 26.7% were of BW <2,500 g. The median (IQR) age at onset was 7 (IQR, 6-16) days after birth, and the median (IQR) time from symptom onset to confirmed diagnosis was 5 (IQR, 1-10) days. The most common presenting signs were fever, local swelling and reduced mobility of the affected segment. Femur was the most frequently affected site (66.7%) and 73.3% neonates had ≥2 bones involved. Conclusions: Neonates with osteomyelitis required a long duration of antibiotics and had a high rate of sequelae. The treatment of neonatal osteomyelitis remains challenging, especially for those with negative culture. Further research is needed to investigate the proper duration of antibiotics administration and the indicators for switching antibiotics from intravenous to oral therapy for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.